Weijie Gu Selected Research

brivudine (brivudin)

2/2021	Drug Discovery of Nucleos(t)ide Antiviral Agents: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Birthday.
1/2021	Life-long passion for antiviral research and drug development: 80th birthday of Prof. Dr. Erik De Clercq.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weijie Gu Research Topics

Disease

12	Neoplasms (Cancer) 01/2021 - 01/2015
8	Renal Cell Carcinoma (Grawitz Tumor) 05/2021 - 01/2014
4	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 07/2015
2	Retinitis 02/2021 - 01/2021
2	Acquired Immunodeficiency Syndrome (AIDS) 02/2021 - 01/2021
2	Lymphoma (Lymphomas) 02/2021 - 01/2021
2	Communicable Diseases (Infectious Diseases) 02/2021 - 01/2021
2	Penile Neoplasms (Penile Cancer) 01/2020 - 10/2017
2	Neoplasm Metastasis (Metastasis) 04/2018 - 05/2016
2	Melanoma (Melanoma, Malignant) 07/2013 - 01/2012
1	HIV Infections (HIV Infection) 02/2021
1	Infections 02/2021
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 02/2021
1	Hepatitis B 01/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Multiple Myeloma 01/2021
1	Human Influenza (Influenza) 01/2021
1	Hepatitis C 01/2021
1	Vitiligo 10/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Papillomavirus Infections 01/2020
1	Obesity 01/2016
1	Diabetes Mellitus 01/2014
1	Hypertension (High Blood Pressure) 01/2014
1	Ocular Albinism type 1 01/2012
1	Cutis Laxa 09/2011
1	Anetoderma 09/2011

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 04/2018 - 09/2011
2	brivudine (brivudin)IBA 02/2021 - 01/2021
2	adefovir dipivoxil (Hepsera)FDA Link 02/2021 - 01/2021
2	tenofovir alafenamideIBA 02/2021 - 01/2021
2	rabacfosadineIBA 02/2021 - 01/2021
2	Tenofovir (Viread)FDA Link 02/2021 - 01/2021
2	Cidofovir (Vistide)FDA Link 02/2021 - 01/2021
2	Valacyclovir (Valtrex)FDA LinkGeneric 02/2021 - 01/2021
2	Stavudine (Zerit)FDA LinkGeneric 02/2021 - 01/2021
2	NucleotidesIBA 02/2021 - 01/2021
2	Antiviral Agents (Antivirals)IBA 02/2021 - 01/2021
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2021 - 07/2015
2	Sunitinib (Sutent)FDA Link 01/2019 - 05/2016
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 12/2017 - 01/2017
2	CytokinesIBA 01/2016 - 01/2014
2	IgA receptor (protein B)IBA 07/2013 - 01/2012
2	Glycoproteins (Glycoprotein)IBA 07/2013 - 01/2012
1	Androgen Antagonists (Antiandrogens)IBA 01/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	pazopanib FDA Link 05/2021
1	sintilimabIBA 05/2021
1	GuanosineIBA 02/2021
1	NucleosidesIBA 02/2021
1	CytidineIBA 02/2021
1	Adenosine (Adenocard)FDA LinkGeneric 02/2021
1	ThymidineIBA 02/2021
1	plerixafor FDA Link 01/2021
1	xenon chlorideIBA 10/2020
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	C-Reactive ProteinIBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	PlatinumIBA 10/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	Sorafenib (BAY 43-9006)FDA Link 08/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016
1	AdiponectinIBA 01/2016
1	LeptinIBA 01/2016
1	Indicators and Reagents (Reagents)IBA 01/2015
1	ElementsIBA 07/2013
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2012
1	Tissue Inhibitor of Metalloproteinase-1IBA 09/2011
1	Metalloproteases (Metalloproteinases)IBA 09/2011
1	CollagenIBA 09/2011
1	Matrix Metalloproteinases (MMPs)IBA 09/2011

Therapy/Procedure

6	Therapeutics 05/2021 - 01/2014
2	Castration 01/2022 - 01/2020
1	Lasers (Laser) 10/2020
1	Phototherapy (Light Therapy) 10/2020
1	Excimer Lasers 10/2020
1	Drug Therapy (Chemotherapy) 10/2017